Medmo is a technology company.
Medmo has raised $20.0M across 2 funding rounds.
Medmo has raised $20.0M in total across 2 funding rounds.
Medmo has raised $20.0M in total across 2 funding rounds.
Medmo's investors include Gradient Ventures, Gadi Porat, Lerer Hippeau, Elliott Cohen, D.F.A. Capital, FirstHand Alliance, Jerusalem Venture Partners (JVP), MizMaa Ventures, Pantera Capital, Tucker Seed Fund LLC, Vast Ventures.
Medmo is a healthcare technology startup that provides an AI-powered platform for providers to order, schedule, and track medical imaging appointments like MRIs, CT scans, and PET scans.[2][4] It serves ordering providers across specialties, including orthopedics, in all 50 states, solving inefficiencies in imaging referrals such as delayed appointments, low adherence rates, high administrative costs, and exams in expensive settings by guiding patients to high-value in-network centers, boosting completion rates, and closing the care loop with real-time updates.[2][4] Medmo has raised $15 million in a Series A round and previously $9 million in funding, demonstrating strong growth momentum with partnerships like Sorin Medical and claims of 30% higher patient adherence and 95% reduced staff time on referrals for clients.[1][4][5]
Medmo was founded in 2017 and incorporated on October 27, 2017, in New York City, with Dr. Christopher Kelly MD as CEO and Lucas Takahashi as co-founder.[3] Operating from 122 Grand Street in Chinatown, NY, the company emerged to address patient pain points in medical imaging—long waits, unnecessary travel, and high costs—while easing administrative burdens for providers and optimizing capacity for imaging centers.[3][5] Early traction included BBB accreditation in 2019 and funding rounds, with a $9 million raise led by Lerer Hippeau alongside Jerusalem Venture Partners (JVP), C2 Ventures, Stone IsraVentures, and angels, followed by a $15 million Series A to fuel expansion.[1][5]
Medmo rides the value-based care trend in healthcare, where reducing costs and improving outcomes amid rising imaging expenses aligns with payer pressures and regulations like HEDIS/Star ratings.[2][4] Its timing capitalizes on post-pandemic diagnostic backlogs, AI-driven coordination needs, and a fragmented $100+ billion U.S. imaging market strained by administrative inefficiencies.[4][5] Market forces favoring Medmo include health system consolidation, insurer demands for in-network utilization, and tech adoption by 60%+ of U.S. systems via platforms like Elion, positioning it to influence ecosystems by streamlining referrals and boosting adherence across providers.[2]
Medmo's platform positions it for scaled adoption as AI care coordination matures, with next steps likely expanding enterprise partnerships, enhancing AI for predictive scheduling, and entering adjacent diagnostics amid value-based shifts.[4][5] Trends like telehealth integration and payer-provider alignments will amplify its efficiencies, potentially evolving its influence from niche imaging optimizer to broader diagnostic orchestrator, tying back to its core mission of making high-quality care accessible and seamless for patients and providers.[2][4]
Medmo has raised $20.0M across 2 funding rounds. Most recently, it raised $15.0M Series A in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2025 | $15.0M Series A | Gradient Ventures, Gadi Porat, Lerer Hippeau, Elliott Cohen | |
| Nov 1, 2023 | $5.0M Seed | D.F.A. Capital, FirstHand Alliance, Gradient Ventures, Gadi Porat, Jerusalem Venture Partners (JVP), Lerer Hippeau, MizMaa Ventures, Pantera Capital, Tucker Seed Fund LLC, Vast Ventures, Elliott Cohen |